We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Cell Chip Tackles Medical Imaging

By Biotechdaily staff writers
Posted on 25 Apr 2007
Scientists have exploited parallel computer architecture and memory bandwidth to significantly speed up the processing of three-dimensional (3D) medical images. More...


This new development considerably supports image registration--the computer-enhanced alignment of two medical images obtained at different dates or by using different imaging devices, in three-dimensional space. With the images correctly aligned over one another, a radiologist can more effectively detect structural changes such as the growth or shrinkage of tumors.

The collaboration‘s findings, by researchers from the Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA), were presented at the IEEE (Institute of Electrical and Electronics Engineers) International Symposium on Biomedical Imaging in Washington, DC, USA, April 12-15, 2007.

Through porting and optimization of Mayo Clinic's Image Registration Application on the IBM BladeCenter QS20 Cell Blade, the application produced image results 50 times faster than the application running on a conventional processor configuration.

One way medical images are being improved is by using visual images from more than one source--magnetic resonance imaging (MRI) and computed tomography (CT) scans, for example. The generation of computer-enhanced images from multiple sources must start with the accurate alignment of the visual data. When three dimensions and millions of pixels are involved, the task becomes exponentially complicated. Within this scope, the need for higher processing speeds is vital.

For this imaging project, Mayo Clinic and IBM utilized 98 sets of images and ran the optimized registration application on the IBM BladeCenter QS20, in comparison with running the original application on a typical processor configuration. The application running on a typical processor configuration completed the registration of all 98 sets of images in about seven hours. The team adapted a mutual-information-based 3D linear registration algorithm application optimized for Cell Broadband Engine (Cell/BE) and completed the registration for all 98 sets of images in just 516 seconds, with no registration taking more than 20 seconds.

By running the application faster, a clinician will be able to make a faster diagnosis and promptly begin appropriate treatments for patients. "This is all about taking technology innovation, collaborating with our customers, and applying it to help them directly benefit their patients,” said Shahrokh Daijavad, Next Generation Computing, Systems, and Technology, IBM.


Related Links:
IBM
Mayo Clinic

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.